Add BrightSurf on Google Email

In Mass General Brigham-led phase 2 trial, novel therapy significantly reduced triglyceride levels

A phase 2b clinical trial led by Mass General Brigham researchers shows that MAR001 can significantly reduce triglyceride levels within 12 weeks for patients with high triglyceride levels. The therapy targets ANGPTL4, a protein that naturally inhibits lipoprotein lipase, an enzyme that breaks down triglycerides.

SourceMass General Brigham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 9, 2026

A healthier form of salt could prevent millions of deaths from stroke and heart disease

A global switch to potassium-enriched salt could prevent nearly three million deaths and ten million new cases of cardiovascular and kidney disease each year. Potassium-enriched salt, which replaces some sodium chloride with potassium chloride, addresses both high blood pressure and sodium intake issues.

SourceGeorge Institute for Global Health·JournalNature Health·TypeComputational simulation/modeling·DateNov 4, 2026

Good sleep linked to better brain health in cardiometabolic disease

Research from Karolinska Institutet found that people with type 2 diabetes, heart disease, or stroke who sleep well perform better on cognitive tests and have larger brain volumes than those who sleep poorly. This study suggests that healthy sleep may help mitigate the negative effects of cardiometabolic disease on brain health.

SourceKarolinska Institutet·JournalJournal of the American Heart Association·TypeObservational study·DateNov 4, 2026

Can drinking tea help protect against cardiovascular disease?

A study found that regular tea consumption was linked with an 11% lower risk of cardiovascular disease, with the lowest risk estimated at approximately 6–8 cups per day among weekly drinkers. Black tea showed more consistent inverse associations with vascular disease than green tea.

SourceWiley·JournalJournal of Internal Medicine·DateOct 21, 2026

Gene editing is coming for common diseases. Are we ready?

Gene therapies can already change clinical care, but their use in common conditions raises concerns about permanent harm and competition with existing treatments. Cardiologists propose strategies for determining when genomic therapy is justified, including considering the benefits, risks, and long-term safety monitoring.

SourceMichigan Medicine - University of Michigan·JournalJAMA Internal Medicine·TypeCommentary/editorial·DateOct 20, 2026

Exercise should be prescribed as a core component of cardiovascular care

A new American College of Cardiology Scientific Statement recommends prescribing exercise that is safe, achievable and sustainable over time to treat and prevent heart disease. Regular physical activity improves exercise capacity, reduces hospitalization and enhances quality of life, with small increases producing meaningful benefits.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 15, 2026

Researchers discover a commonly prescribed blood-pressure drug may stimulate “healthy” brown fat

Researchers discovered that losartan, a commonly prescribed blood-pressure drug, stimulates brown adipose tissue activity in mice, enhancing their metabolism. This finding suggests that repurposing losartan may be a clinically viable method of stimulating brown fat, which has been linked to improved cardiovascular health and, for the f...

SourceRockefeller University·JournalNature·DateOct 14, 2026

Anabolic steroids linked to serious heart damage in weightlifters; stopping them may aid recovery

A study found that long-term use of anabolic-androgenic steroids causes sustained thickening of the heart's left ventricular wall and impaired contractions. Stopping anabolic steroids completely can reverse these effects, with 15 participants showing a significant reduction in heart muscle thickness and improved cardiac function.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal - Cardiovascular Imaging·DateOct 12, 2026

Heart disease gaps persist despite overall declines

Despite overall declines in US cardiovascular disease mortality, racial, ethnic, and place-based disparities persist, with significant gaps in mortality rates across counties and states. The analysis highlights the need for targeted clinical and public health practices to address these disparities and promote heart health equity.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 7, 2026

Digital alerts support timely treatment decisions of critically ill cardiac patients

Researchers found that well-designed digital alerts can assist clinicians in high-pressure situations, prompting them to make recommended treatment decisions and recognize when patients are deteriorating. The studies demonstrated the effectiveness of electronic health record alerts in the emergency department and cardiac intensive care...

SourceMichigan Medicine - University of Michigan·JournalJACC Case Reports·TypeObservational study·DateOct 6, 2026

Mass General Brigham women’s heart health leader to receive the 2026 Dr. Nanette K. Wenger Research Goes Red® Award

Dr. Emily Lau's research found that maternal cardiovascular disease and pregnancy-related cardiovascular complications increased over nearly two decades, with higher rates among non-Hispanic Black women. The study emphasizes the need to make cardiovascular health a routine part of care before, during, and after pregnancy to address dis...

Overall diet quality key to heart health

The American College of Cardiology emphasizes a plant-forward diet rich in vegetables, fruits, whole grains, and healthy fats to prevent and manage cardiovascular disease. Consensus recommendations include a focus on overall dietary quality and sustainability over individual nutrients or trends.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateSep 30, 2026

New $3.1M NIH grant for University of Houston to study how ‘spongy heart’ disease develops — and whether it can be stopped

University of Houston researcher Mingfu Wu has received a $3.1 million NIH grant to investigate left ventricular noncompaction, a serious heart condition that can lead to heart failure and abnormal heart rhythms. The study aims to uncover a common mechanism behind different genetic causes of LVNC and potentially identify new targets fo...

Cardiac rehabilitation cuts hospital admissions and heart attack risk

Exercise-based cardiac rehabilitation reduces hospital admissions by a third and heart attack risk by more than a quarter, with long-term benefits and cost-effectiveness. Digital programmes can be just as effective as traditional centre-based services, making rehabilitation more accessible.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateSep 17, 2026

Cardiovascular disease tops cancer as leading cause of death among Hispanic adults in U.S.

A new American Heart Association scientific statement reveals that cardiovascular disease has surpassed cancer as the leading cause of death among Hispanic adults in the U.S. due to rising rates of obesity, diabetes, and high blood pressure. The statement highlights the need for culturally tailored prevention strategies, equitable acce...

SourceAmerican Heart Association·JournalCirculation·DateSep 15, 2026

Reducing infections after heart surgery could save Medicare $441 million per year

A new study by Michigan Medicine found that heart surgery infection rates vary significantly across U.S. hospitals, with some experiencing nearly double the risk of others. By reducing infections, hospitals could prevent 2,600 infections and reduce Medicare spending by $441 million annually.

SourceMichigan Medicine - University of Michigan·JournalJournal of Thoracic and Cardiovascular Surgery·TypeObservational study·DateSep 15, 2026

Family Heart Foundation study demonstrates how the FIND Lp(a) machine learning model enables targeted Lp(a) screening

The study demonstrates the FIND Lp(a) model's ability to identify individuals with high Lp(a) more than twice as likely as the overall population with ASCVD. The model supports targeted Lp(a) screening, accelerating universal screening adoption and enhancing cardiovascular risk management.

SourceFamily Heart Foundation·JournalJACC Advances·TypeData/statistical analysis·DateSep 14, 2026

Protein clues in the blood may help children avoid diseases later in life

Researchers have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that can be reversed with a new class of weight loss drugs. The study found that levels of certain disease-associated proteins in children decline in response to therapy with semaglutide, a GLP-1 receptor agonis...

SourceVanderbilt University Medical Center·JournalNature Metabolism·DateSep 11, 2026

New U‑VBA pipeline standardizes super‑resolution ultrasound for microvascular disease assessment

A new platform enables non-invasive tracking of early microvascular disease changes using ultrasound localization microscopy. The U-VBA framework standardizes analysis of tiny blood vessels, capturing structural and hemodynamic properties, and shows high reproducibility and accuracy in classification of cervical lymph-node conditions.

SourceBMEF (BME Frontiers)·JournalBME Frontiers·DateSep 9, 2026

Mental health conditions after trauma linked to higher cardiovascular risk

Research suggests that mental health conditions, including PTSD, substance abuse, and depression, can increase the risk of future cardiovascular risks such as heart attacks, strokes, and cardiovascular death. Alcohol abuse was found to be the top psychiatric predictor of serious heart and brain conditions for both men and women.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateSep 2, 2026